MiR-30a inhibits glioma progression and stem cell-like properties by repression of Wnt5a

18Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

miR-30a has been found to be dysregulated in diverse cancers and involved in the regulation of tumor progression. However, there is scarce research on the role of miR-30a in glioma. In the present study, we assessed the expression level of miR-30a in glioma tissues and cell lines. The microRNA microarray analysis revealed low expression of miR-30a in glioma tissues and cells vs. The control. Furthermore, we found that stable miR-30a inhibited cell proliferation, G1 phase arrest and stem cell-like formation in glioma. Moreover, to investigate the molecular mechanism of miR-30a on glioma cell phenotypes, we identified Wnt5a as a new direct target gene for miR-30a by bioinformatic assay, luciferase assay and western blot analysis. Further functional studies suggested that miR-30a suppressed metastasis, sphere formation and glioma growth by targeting Wnt5a signal pathway. Collectively, our findings suggested for the first time that miR-30a may function as a tumor suppressor in glioma by targeting Wnt5a.

Cite

CITATION STYLE

APA

Zhang, Y., Wu, Z., Li, L., & Xie, M. (2017). MiR-30a inhibits glioma progression and stem cell-like properties by repression of Wnt5a. Oncology Reports, 38(2), 1156–1162. https://doi.org/10.3892/or.2017.5728

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free